Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis
A 34-year-old female patient presented during the 10th week of her second gravidity with headache, nausea and vomiting 2 weeks before admission. Her medical history was remarkable for a heterozygous factor V Leiden mutation, elevated lipoprotein A, and a cerebral venous thrombosis (CVT) after oral c...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-12-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286419895157 |
id |
doaj-59c2f6e6416b4e51ad9a5abc1ef0d938 |
---|---|
record_format |
Article |
spelling |
doaj-59c2f6e6416b4e51ad9a5abc1ef0d9382020-11-25T03:35:04ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642019-12-011210.1177/1756286419895157Management of a decompensated acute-on-chronic intracranial venous sinus thrombosisCarmen Serna CandelVictoria HellsternTania BeitlichMarta Aguilar PérezHansjörg BäznerHans HenkesA 34-year-old female patient presented during the 10th week of her second gravidity with headache, nausea and vomiting 2 weeks before admission. Her medical history was remarkable for a heterozygous factor V Leiden mutation, elevated lipoprotein A, and a cerebral venous thrombosis (CVT) after oral contraceptive intake 15 years before. Magnetic resonance imaging (MRI) suggested acute and massive intracranial sinus thrombosis. Despite full-dose anticoagulation, the patient deteriorated clinically and eventually became comatose. Now, MRI/magnetic resonance angiography revealed vasogenic edema of both thalami, of the left frontal lobe, and of the head of the caudate nucleus, with venous stasis and frontal petechial hemorrhage. She was referred for endovascular treatment. Diagnostic angiography confirmed a complete superficial and deep venous sinus occlusion. Endovascular access to the straight and superior sagittal sinus was possible, but neither rheolysis nor balloon angioplasty resulted in recanalization of the venous sinuses. Monitored heparinization was continued and antiaggregation was initiated. The patient remained comatose for another 5 days and MRI showed progress of the cytotoxic edema. On day 6, infusion of eptifibatide at body-weight-adapted dosage was started. The following day, the patient improved and slowly regained consciousness. MRI confirmed regression of the edema. The eptifibatide infusion was continued for a total of 14 days. Thereafter two doses of 180 mg ticagrelor per os (PO) daily were started. The patient remained on acetylsalicylic acid (ASA), ticagrelor, and enoxaparin on an unchanged dosage regimen. She was discharged home 26 days after the endovascular treatment without serious neurological deficit, with the pregnancy intact. At the 30th week of pregnancy the dosage of ASA was reduced to 300 mg once PO daily. Cesarian delivery was carried out at the 38th week of pregnancy. The newborn was completely healthy. Ultima ratio therapeutic options for severe intracranial venous sinus thrombosis refractory to anticoagulation are discussed, with an emphasis on platelet-function inhibition.https://doi.org/10.1177/1756286419895157 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carmen Serna Candel Victoria Hellstern Tania Beitlich Marta Aguilar Pérez Hansjörg Bäzner Hans Henkes |
spellingShingle |
Carmen Serna Candel Victoria Hellstern Tania Beitlich Marta Aguilar Pérez Hansjörg Bäzner Hans Henkes Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis Therapeutic Advances in Neurological Disorders |
author_facet |
Carmen Serna Candel Victoria Hellstern Tania Beitlich Marta Aguilar Pérez Hansjörg Bäzner Hans Henkes |
author_sort |
Carmen Serna Candel |
title |
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis |
title_short |
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis |
title_full |
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis |
title_fullStr |
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis |
title_full_unstemmed |
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis |
title_sort |
management of a decompensated acute-on-chronic intracranial venous sinus thrombosis |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Neurological Disorders |
issn |
1756-2864 |
publishDate |
2019-12-01 |
description |
A 34-year-old female patient presented during the 10th week of her second gravidity with headache, nausea and vomiting 2 weeks before admission. Her medical history was remarkable for a heterozygous factor V Leiden mutation, elevated lipoprotein A, and a cerebral venous thrombosis (CVT) after oral contraceptive intake 15 years before. Magnetic resonance imaging (MRI) suggested acute and massive intracranial sinus thrombosis. Despite full-dose anticoagulation, the patient deteriorated clinically and eventually became comatose. Now, MRI/magnetic resonance angiography revealed vasogenic edema of both thalami, of the left frontal lobe, and of the head of the caudate nucleus, with venous stasis and frontal petechial hemorrhage. She was referred for endovascular treatment. Diagnostic angiography confirmed a complete superficial and deep venous sinus occlusion. Endovascular access to the straight and superior sagittal sinus was possible, but neither rheolysis nor balloon angioplasty resulted in recanalization of the venous sinuses. Monitored heparinization was continued and antiaggregation was initiated. The patient remained comatose for another 5 days and MRI showed progress of the cytotoxic edema. On day 6, infusion of eptifibatide at body-weight-adapted dosage was started. The following day, the patient improved and slowly regained consciousness. MRI confirmed regression of the edema. The eptifibatide infusion was continued for a total of 14 days. Thereafter two doses of 180 mg ticagrelor per os (PO) daily were started. The patient remained on acetylsalicylic acid (ASA), ticagrelor, and enoxaparin on an unchanged dosage regimen. She was discharged home 26 days after the endovascular treatment without serious neurological deficit, with the pregnancy intact. At the 30th week of pregnancy the dosage of ASA was reduced to 300 mg once PO daily. Cesarian delivery was carried out at the 38th week of pregnancy. The newborn was completely healthy. Ultima ratio therapeutic options for severe intracranial venous sinus thrombosis refractory to anticoagulation are discussed, with an emphasis on platelet-function inhibition. |
url |
https://doi.org/10.1177/1756286419895157 |
work_keys_str_mv |
AT carmensernacandel managementofadecompensatedacuteonchronicintracranialvenoussinusthrombosis AT victoriahellstern managementofadecompensatedacuteonchronicintracranialvenoussinusthrombosis AT taniabeitlich managementofadecompensatedacuteonchronicintracranialvenoussinusthrombosis AT martaaguilarperez managementofadecompensatedacuteonchronicintracranialvenoussinusthrombosis AT hansjorgbazner managementofadecompensatedacuteonchronicintracranialvenoussinusthrombosis AT hanshenkes managementofadecompensatedacuteonchronicintracranialvenoussinusthrombosis |
_version_ |
1724555725033701376 |